Elipse Balloon from Allurion Technologies
Boston-based Allurion Technologies has raised $27 million in Series C funding to commercialize its intragastric balloon device. Contributors included current investor Romulus Capital, along with Cogepa Investments and IDO Investments.
“The funding…
Source: medcitynews.com – Read more

SMB cybersecurity in 2026: From reactive defense to strategic partnership
Strategic partners help UK SMBs navigate cyber regulations and bridge leadership gaps


